QUALITY OF HERBAL REMEDIES

Similar documents
Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

H e r b a l M e dicines' Q U A L I T Y M ANUAL. I. Introduction

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

QUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS

AD HOC WORKING GROUP ON HERBAL MEDICINAL PRODUCTS

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Discussion at the HMPC January March Draft agreed by Quality Working Party April Adoption by CHMP for release for consultation 26 May 2005

2. Selection criteria for substances of herbal origin relevant for standardization and quality control of herbal medicines 77

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

Questions & answers on quality of herbal medicinal products/traditional herbal medicinal products 1

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

European Medicines Agency COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

HERBAL MEDICINES: Product Licence To Traditional Herbal Registration in the UK. Presented by: Mariam Aslam

REPORT FROM THE AD HOC WORKING GROUP ON HERBAL MEDICINAL PRODUCTS 1997/1998

Decision tree for the safety assessment of botanical cosmetic ingredients. Personal Care Products Council CIR Science and Support Committee

Direction générale Médicaments

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

WHO guidelines on good manufacturing practices (GMP) for herbal medicines

European Medicines Agency Inspections

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG)

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS

European Union legislation on Food additives, Food enzymes, Extractions solvents and Food flavourings

GOOD PHARMACOPOEIAL PRACTICES Draft chapter on monographs on herbal medicines

Wholistic Approach to Herbal Products Quality Case Study: Thyme

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

Public Assessment Report Scientific discussion

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL PROCEDURE FOR THE PREPARATION OF COMMUNITY MONOGRAPHS FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS

Quality Control of Herbal Products. Dr. Fabio Boylan

Draft agreed by HMPC Quality Drafting Group October Adopted by HMPC 12 November 2013

SHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE

Dormeasan, oral drops, solution (Valeriana officinalis L., radix, tincture; Humulus lupulus L., strobulus, tincture)

Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON AVENA SATIVA L., HERBA

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

Public Assessment Report Scientific discussion

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON EQUISETUM ARVENSE L., HERBA

Public Assessment Report Scientific discussion. Ginsana, soft capsule. Asp.no.:

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES

DETERMINATION OF MICROBIAL CONTAMINANTS IN SOME MARKETED HERBAL FORMULATION

Public Assessment Report Scientific discussion

Public Assessment Report Scientific discussion

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ECHINACEA PALLIDA (NUTT.) NUTT., RADIX

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON SOLIDAGO VIRGAUREA L., HERBA

Public Assessment Report Scientific discussion. Echinaforce Forte, tablet. Asp. No:

European Medicines Agency Evaluation of Medicines for Human Use COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON PASSIFLORA INCARNATA L., HERBA

Prof. Marina Heinonen University of Helsinki Member of the NDA Panel and EFSA s WG on Novel Foods

Public Assessment Report Scientific discussion. Ginsana, oral solution. Asp.no.:

European Medicines Agency Evaluation of Medicines for Human Use. Superseded COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

REGISTRATION OF HERBAL AND COMPLEMENTARY PRODUCTS

MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ALTHAEA OFFICINALIS L., RADIX

European Medicines Agency. Superseded COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON SALVIA OFFICINALIS L.

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL VOLUME 2C. Guidelines. Medicinal products for human use

Opinion on the safety assessment of phospholipds obtained from egg yolk as food produced using a new process

Public Assessment Report. Scientific discussion. Pentasa Compact 4 g, prolonged-release granules. (mesalazine) NL License RVG:

on the approximation of the laws of the Member States concerning food additives authorized for use in foodstuffs intended for human consumption

Emanuela Turla Scientific Officer Nutrition Unit - EFSA

Guide to Registration of Homeopathic Veterinary Medicinal Products

GUIDANCE ON SUBMISSIONS FOR SAFETY EVALUATION OF SOURCES OF NUTRIENTS OR OF OTHER INGREDIENTS PROPOSED FOR USE IN THE MANUFACTURE OF FOODS

Public Assessment Report Scientific discussion. Prospan, oral solution (Hedera helix L. folium; dry extract (DER 5-7.

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Stability Testing of Herbal Medicinal Products

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

Guide. homoeopathic preparations. for the elaboration of monographs on

General concepts in the Ph. Eur.: theory and rationale

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope

Public Assessment Report Scientific discussion

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use

(Non-legislative acts) REGULATIONS

Savesta Herbals is engaged in manufacturing

MEDICINES CONTROL COUNCIL

Expectations for Implementation in Europe

Quality control of herbal drug

COMMISSION DIRECTIVE 97/48/ EC. of 29 July 1997

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON THYMUS VULGARIS L. AND THYMUS ZYGIS L., HERBA

Guidance notes on the classification of food extracts with colouring properties Last update [ ]

Official Journal of the European Union L 109/11

Public Assessment Report Scientific discussion

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON AESCULUS HIPPOCASTANUM L., SEMEN

TECHNICAL REPORT OF EFSA. List of guidance, guidelines and working documents developed or in use by EFSA 1

OVERVIEW OF COMMENTS RECEIVED ON COMMUNITY HERBAL MONOGRAPH ON HAMAMELIS VIRGINIANA L., FOLIUM (EMEA/HMPC/114586/2008)

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON VALERIANA OFFICINALIS L., RADIX AND HUMULUS LUPULUS L.

USP botanical quality standards: contributions in quality control & safe use of botanicals

COMMISSION DIRECTIVE 2011/3/EU

Thank you for your requests under the Freedom of Information Act Please find below responses to your questions.

GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE

MEDICINES CONTROL COUNCIL

Transcription:

QUALITY OF HERBAL REMEDIES Guideline Title Quality of Herbal Remedies Legislative basis Directive 75/318/EEC as amended Date of first adoption November 1988 Date of entry into May 1989 force Status Last revised 1988 Previous titles/other None references Additional Notes This note for guidance concerns the application to herbal based remedies of Part 2 of the Annex to Directive 75/318/EEC as amended, with a view to the granting of a marketing authorisation for a medicinal product. CONTENTS A QUALITATIVE AND QUANTITATIVE PARTICULARS OF THE CONSTITUENTS B DESCRIPTION OF THE METHOD OF PREPARATION C CONTROL OF STARTING MATERIALS D CONTROL OF TESTS CARRIED OUT AT AN INTERMEDIATE STAGE OF THE MANUFACTURING PROCESS OF THE FINISHED PRODUCT E CONTROL TESTS ON FINISHED PRODUCT F STABILITY TESTS ANNEX 195

QUALITY OF HERBAL REMEDIES Note for guidance concerning the application of Part 2 of the Annex to Directive 75/318/EEC as amended. The special problems of herbal remedies and the differences between medicinal products containing chemically defined active substances are described in this note for guidance. Consistent quality for products of vegetable origin can only be assured if the starting materials are defined in a rigorous and detailed manner including especially the specific botanical identification of the plant material used. It is also important to know the geographical source and the conditions under which the vegetable substance is obtained to ensure material of consistent quality. Reference substances used in the control of all stages of the manufacturing process should be clearly defined. A QUALITATIVE AND QUANTITATIVE PARTICULARS OF THE CONSTITUENTS 1. In the case of a vegetable substance either a) the quantity of vegetable substance must be stated or b) the quantity of a vegetable substance may be given as a range corresponding to a defined quantity of constituents with known therapeutic activity. EXAMPLE a) Active substance 900 mg or b) Active substance 830-1000 mg, corresponding to 25 mg of hydroxyanthracene glycosides, calculated as Sennoside B Other substance 0-170 mg, corresponding to the quantity of Sennae folium 197

3AQ22a 2. In the case of a vegetable substance preparation either a) the equivalent quantity, or the ratio e.g. 8:1 of the vegetable substance to the vegetable substance preparation must be stated (this does not apply to fatty or essentials oils). or b) the quantity of the vegetable substance preparation may be given as a range corresponding to a defined quantity of constituents with know therapeutic activity (see example). The composition of any solvent or solvent mixture and the physical state of the extract must be indicated. If any other substance is added during the manufacture of the vegetable substance preparation to adjust the vegetable substance preparation to a certain level of constituents with known therapeutic activity, or for any other purpose, the added substance must be mentioned as an other substance and the genuine extract as the active substance. EXAMPLE a) Active substance 125 mg dry 60% ethanolic extract (8:1) or 125 mg equivalent to 1000 mg dry 60% ethanolic extract or b) Active substance dry 60% ethanolic extract (8:1) 100-130 mg, corresponding to 25 mg of hydroxyanthracene glycosides, calculated as Sennoside B Other substances Dextrin 20-50 mg 198

B DESCRIPTION OF THE METHOD OF PREPARATION The manufacturing process within the meaning of this section is the preparation of the finished product from the starting materials. The description should include details of any comminution or size reduction step, and details of any process such as fumigation etc. used to reduce the levels of microbial contamination together with the controls exercised over the process. If vegetable substance preparations are the starting material, the manufacture of the vegetable substance preparations and their controls do not belong under this section but under section C. C CONTROL OF STARTING MATERIALS 1. Control of the vegetable substance A complete monograph for each vegetable substance must be submitted, even if the starting material is a vegetable substance preparation. This also applies if the applicant is not the manufacturer of the preparation. In the case of fatty or essential oils a complete monograph for the vegetable substance is not required, only the scientific name of the parent plant and its part(s) have to be stated. If no monograph for the vegetable substance is given in a Pharmacopoeia referred to i n Directive 75/318/EEC as amended, Annex 1, a monograph on the vegetable substance must be supplied and should be set out in the same way where practicable, as the monographs on vegetable substances in the European Pharmacopoeia. This should include the botanical name and authority and the common name if used for labelling purposes. Information on the site of collection, the time of harvesting and stage of growth, treatment during growth with pesticides etc., and drying and storage conditions should be included if possible. The monograph should be established on the basis of recent scientific data. In the case of vegetable substances with constituents of known therapeutic activity, assays of their content (with test procedure) are required. The content must be included as a range, so as to ensure reproducibility of the quality of the finished product. As a general rule, vegetable substances must be tested for microbiological quality and for residues of pesticides and fumigation agents, radioactivity, toxic metals, likely contaminants and adulterants, etc., unless otherwise justified. Specifications and descriptions of the analytical procedures must be submitted, together with the limits applied. Reference samples of the vegetable substances must be available for use in comparative tests e.g. macro and microscopic examination, chromatography etc. 2. Control of vegetable substance preparations If the herbal remedy contains not the vegetable substance itself but a preparation, the monograph on the substance must be followed by a description and validation of the manufacturing process for the vegetable substance preparation. For each vegetable substance preparation, a monograph must be submitted. This must be established on the basis of recent scientific data and must give particulars of the characteristics, identification tests and purity tests. This has to be done e.g. by different appropriate chromatographic methods. If deemed necessary by the results of the analysis of the starting material, tests on microbiological quality, residues of pesticides, fumigation 199

3AQ22a agents, radioactivity, solvents and toxic metals have to be carried out. Quantitative determination (assay) of characteristic constituents is required. The content must be indicated with the lowest possible tolerance. The test methods must be described in detail. If preparations from vegetable substances with constituents with known therapeutic activity are standardised (i.e. adjusted to a certain level of constituents with known therapeutic activity) it must be stated how such standardisation is achieved. If another substance is used for this purpose, it is necessary to specify as a range the quantity that can be added. D CONTROL OF TESTS CARRIED OUT AT AN INTERMEDIATE STAGE OF THE MANUFACTURING PROCESS OF THE FINISHED PRODUCT Details of all control tests with details of test procedures and limits applied at any intermediate stages of the manufacturing processes are required, especially if these tests cannot be done in the finished product. E CONTROL TESTS ON FINISHED PRODUCT The control tests on the finished product must be such as to allow the qualitative and quantitative determination of the composition of the active substances and a specification has to be given which may be done by using markers if constituents with known therapeutic activity are unknown. In the case of vegetable substances or vegetable substance preparations with constituents of known therapeutic activity, these constituents must also be specified and quantitatively determined. If a herbal remedy contains several vegetable substances or preparations of several vegetable substances and it is not possible to perform a quantitative determination of each active substance, the determination may be carried out jointly for several active substances. The need for this procedure must be justified. F STABILITY TESTS Since the vegetable substance or vegetable substance preparation in its entirety is regarded as the active substance, a mere determination of the stability of the constituents with known therapeutic activity will not suffice. It must also be shown, as far as possible e.g. by means of appropriate fingerprint chromatograms, that other substances present in the vegetable substance or in the vegetable substance preparation are likewise stable and that their proportional content remains constant. If a herbal remedy contains several vegetable substances or preparations of several vegetable substances and if it is not possible to determine the stability of each active substance, the stability of the medicinal product should be determined by appropriate fingerprint chromatograms, appropriate overall methods of assay and physical and sensory tests or other appropriate tests. If the only evidence that can be submitted concerning the stability of the finished product consists of results of trials in which each active substance was separately tested in a 200

formulation corresponding to that of the finished product, the reasons why it is not possible to carry out stability tests on the finished product must be stated in full. It must furthermore be shown that interactions between the active substances and the excipients in the finished product are unlikely to occur. 201

3AQ22a ANNEX Glossary Herbal remedies (herbal medicines) are medicinal products containing as active substances exclusively plant material and/or vegetable substance preparations. Vegetable substances are plant material used for a medicinal purpose. A vegetable substance or a preparation thereof is regarded as one active substance in its entirety whether or not the constituents with therapeutic activity are known. Vegetable substance preparations are comminuted or powdered vegetable substances, extracts, tinctures, fatty or essential oils, expressed juices etc. prepared from vegetable substances, and preparations whose production involves a fractionation, purification or concentration process. However, chemically defined isolated constituents or their mixtures are not vegetable substance preparations. Other substances such as solvents, diluents, preservatives may form part of vegetable substance preparations. These substances must be indicated. Constituents with known therapeutic activity are chemically defined substances or groups of substances which are known to contribute to the therapeutic activity of a vegetable substance or of a preparation. Markers are chemically defined constituents of a vegetable substance which are of interest for control purposes. Markers may serve to calculate the quantity of vegetable substance or preparation in the finished product if that marker has been quantitatively determined in the vegetable substance or preparation when the starting materials were tested. 202